" /> Zevorcabtagene Autoleucel - CISMeF





Preferred Label : Zevorcabtagene Autoleucel;

NCIt synonyms : Anti-BCMA-CAR-41BB-CD3zeta-expressing T-cells CT053; CT053 CAR-BCMA T Cells; CAR-BCMA T-cells CT053; BCMA Car-T (CT053); CT053 CAR-BCMA T; Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells CT053;

NCIt definition : A preparation of autologous T-lymphocytes that have been transduced with a vector expressing a chimeric antigen receptor (CAR) containing a humanized single chain variable fragment (scFv) specific for the tumor-associated antigen (TAA) B-cell maturation antigen (BCMA; tumor necrosis factor receptor superfamily member 17; TNFRSF17) that is fused to the co-stimulatory domain of 4-1BB (CD137) and the T-cell receptor signaling domain of CD3zeta (CD3z), with potential immunostimulating and antineoplastic activities. Upon administration, zevorcabtagene autoleucel specifically recognize and induce selective toxicity against BCMA-expressing tumor cells. BCMA, a tumor-specific antigen and a receptor for both a proliferation-inducing ligand (APRIL) and B-cell activating factor (BAFF), is a member of the tumor necrosis factor receptor superfamily (TNFRSF) and plays a key role in the survival of B-lymphocytes and plasma cells. BCMA is found on the surfaces of B-cells and is overexpressed on malignant plasma cells.;

UNII : GMV2GFP3G2;

Molecule name : CT-053; CT 053;

NCI Metathesaurus CUI : CL978697;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.